MedTrace Logo

Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room

NCT04726592 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 323

Last updated 2025-09-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room

Conditions

Interventions

DRUG

Clorazepate Dipotassium

Clorazepate Dipotassium : 20 mg intravenous injection

DRUG

Placebo

Placebo IV

DRUG

Ketoprofen

Ketoprofen 100 mg IV

DRUG

Metoclopramide

Metoclopramide 10 mg IV

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-08
Primary Completion
2024-04-10
Completion
2024-04-10

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04726592 on ClinicalTrials.gov